Pfizer Seeks Federal Preemption in Depo-Provera Brain Tumor Litigation

Pfizer Inc. is preparing to mount a federal preemption defense in response to over 400 lawsuits concerning its injectable birth control product, Depo-Provera. The legal proceedings, overseen by U.S. District Judge M. Casey Rodgers in the Northern District of Florida, involve claims that the contraceptive has led to non-malignant brain tumors in women. This multidistrict litigation, established earlier this year, has seen swift developments, including Pfizer reviewing over one million documents and scheduling depositions this month. For a deeper dive into the intricacies of Pfizer’s legal tactics and the implications of this defense strategy, the full context is available in the original article from Law.com.